glp-1 agonist eli lilly releases topline data for new oral | News FDA just approved orforglipron (Foundayo),

In the present study, absolute bioavailability of diosgenin, charantin, and hydroxychalcone was found to be 9, 8.18, and 10.54%, respectively

They're still in your bag

Journal Impact Factor = 2.412, Times Cited = 6 (ResearchGate) Karschner, Erin L et al

It effectively reduces postprandial glucose levels owing to a marked inhibitory effect on gastric emptying, and it also reduces fasting glucose levels and body weight

We expected that LJ-GSH could offer a valuable approach for exploring the biological functions of GSH and potentially serve as a therapeutic technology for GSH-related tumours.

10.21037/jgo-22-341 43 GhoshA.IslamM